A Bayesian tool for optimizing sample size in phase I dose-finding trials for head and neck cancer
The development of effective cancer treatments relies heavily on the successful execution of clinical trials, particularly Phase I trials, which are crucial for determining optimal drug dosages. In head and neck cancer, characterized by complex treatment needs and diverse patient responses, optimizi...
Saved in:
| Main Author: | Sivakamavalli Jeyachandran |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-06-01
|
| Series: | Oral Oncology Reports |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2772906024003819 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Investigating dose finding methods and different priors in Bayesian continual reassessment method
by: Tuba Koc, et al.
Published: (2020-01-01) -
Therapeutic Drug Monitoring of 5-Fluorouracil in Head and Neck Cancer Patients: An Interventional Pilot Study
by: P. Sharmila Nirojini, et al.
Published: (2024-04-01) -
Stereotactic body radiation therapy as initial treatment for head and neck cancer
by: Sivakamavalli Jeyachandran
Published: (2024-06-01) -
Novel therapy: Combined BRAF and MEK inhibitors for locally advanced BRAF V600L–Positive mucosal melanoma in hypopharynx
by: Sivakamavalli Jeyachandran
Published: (2024-06-01) -
COMPARISON OF FREQUENTIST AND BAYESIAN APPROACHES ON SAMPLE SIZE: METHODOLOGIC STUDY
by: Cennet Yıldız, et al.
Published: (2023-06-01)